(Q42407789)

29 October 2017

Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Non-Small-cell Lung Cancer (English)

1 reference

29 October 2017

1 reference

1 reference

1 reference

Charlotte Roach

1

1 reference

29 October 2017

Nancy Zhang

2

1 reference

29 October 2017

Ellie Corigliano

3

1 reference

29 October 2017

Malinka Jansson

4

1 reference

29 October 2017

Grant Toland

5

1 reference

29 October 2017

Gary Ponto

6

1 reference

29 October 2017

Marisa Dolled-Filhart

7

1 reference

29 October 2017

Kenneth Emancipator

8

1 reference

29 October 2017

Dave Stanforth

9

1 reference

29 October 2017

Karina Kulangara

10

1 reference

29 October 2017

21 June 2016

1 reference

Applied Immunohistochemistry & Molecular Morphology

29 October 2017

1 reference

29 October 2017

24

1 reference

29 October 2017

6

1 reference

29 October 2017

392-397

1 reference

Pembrolizumab for the treatment of non-small-cell lung cancer

29 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957959

PD-1 blockade induces responses by inhibiting adaptive immune resistance

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957959

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957959

B7-H1/PD-1 blockade therapy in non-small cell lung cancer: current status and future direction

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957959

Programmed death ligand-1 expression in non-small cell lung cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957959

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957959

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957959

Hallmarks of Cancer: The Next Generation

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957959

PD-1 and its ligands in tolerance and immunity

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957959

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957959

28 May 2018

The B7-CD28 superfamily

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957959

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957959

Tumor B7-H1 and B7-H3 expression in squamous cell carcinoma of the lung.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957959

High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27333219

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical significance of programmed death-1 ligand-1 expression in patients with non-small cell lung cancer: a 5-year-follow-up study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27333219

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Development of a Companion Diagnostic for Pembrolizumab in Non-Small Cell Lung Cancer Using Immunohistochemistry for Programmed Death Ligand-1.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27333219

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/PAI.0000000000000408

1 reference

29 October 2017

1 reference

29 October 2017

PubMed publication ID

27333219

1 reference